- Patent Title: Therapy for Inflammatory Linear Verrucous Epidermal Nevus (ILVEN)
-
Application No.: US17270630Application Date: 2019-08-29
-
Publication No.: US12023318B2Publication Date: 2024-07-02
- Inventor: Veronica Kinsler
- Applicant: UCL Business Ltd
- Applicant Address: GB London
- Assignee: UCL BUSINESS LTD
- Current Assignee: UCL BUSINESS LTD
- Current Assignee Address: GB London
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Priority: GB 14036 2018.08.29
- International Application: PCT/GB2019/052409 2019.08.29
- International Announcement: WO2020/044045A 2020.03.05
- Date entered country: 2021-02-23
- Main IPC: A61K31/37
- IPC: A61K31/37 ; A61K9/00 ; A61K31/575 ; A61K45/06
Abstract:
The present invention provides a pharmaceutical composition which comprises: (a) an HMG-CoA reductase inhibitor; and (b) cholesterol or a pharmaceutically acceptable precursor thereof; for use in treating Inflammatory Linear Verrucous Epidermal Nevus (ILVEN).
Public/Granted literature
- US20210260024A1 NEW THERAPY FOR INFLAMMATORY LINEAR VERRUCOUS EPIDERMAL NEVUS (ILVEN) Public/Granted day:2021-08-26
Information query
